Safety Shot Partners with Gopuff
May 13, 2024 08:34 ET
|
Safety Shot, Inc.
Gopuff, a delivery service that brings thousands of products to your doorstep in minutes, will aid in turning Safety Shot into a household brand. JUPITER, FL, May 13, 2024 (GLOBE NEWSWIRE) --...
Live Ventures Reports Fiscal Second Quarter 2024 Financial Results
May 13, 2024 08:30 ET
|
Live Ventures Incorporated
LAS VEGAS, May 13, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its...
Backblaze to Present at the 19th Annual Needham Technology, Media, & Consumer Conference
May 13, 2024 08:30 ET
|
Backblaze, Inc.
SAN MATEO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Backblaze, Inc. (Nasdaq: BLZE), the leading specialized storage cloud, today announced participation in the following investor conference: ...
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024 08:30 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James...
NANO Nuclear Energy Announces Closing of $10,250,000 Initial Public Offering
May 13, 2024 08:30 ET
|
NANO Nuclear Energy Inc.
First Portable Nuclear Microreactor Company Publicly Listed in the U.S. NANO Nuclear seeking to be a diversified and vertically integrated technology-driven nuclear energy company with a focus on...
Haveli Investments Completes Acquisition of ZeroFox
May 13, 2024 08:30 ET
|
ZeroFox, Inc.
WASHINGTON, May 13, 2024 (GLOBE NEWSWIRE) -- ZeroFox Holdings, Inc. (Nasdaq: ZFOX), a leading provider of external cybersecurity, today announced the completion of its acquisition by...
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
May 13, 2024 08:30 ET
|
Relay Therapeutics, Inc.
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial
May 13, 2024 08:30 ET
|
Ascendis Pharma
COPENHAGEN, Denmark, May 13, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced 2-year results from a post-hoc analysis of the Company’s Phase 3 PaTHway Trial demonstrating...
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
May 13, 2024 08:30 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,...
LM Funding America, Inc. Schedules First Quarter 2024 Financial Results and Business Update Conference Call
May 13, 2024 08:30 ET
|
LM Funding America, Inc.
TAMPA, FL, May 13, 2024 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) ("LM Funding" or the "Company"), a cryptocurrency mining and technology-based specialty finance company, today...